Andere Kunden interessierten sich auch für
![Desenvolvimento de Formulação e Caracterização de Matrix Tablet para CTDD]( "Desenvolvimento de Formulação e Caracterização de Matrix Tablet para CTDD")
Desenvolvimento de Formulação e Caracterização de Matrix Tablet para CTDD39,99 €![Formulierungsentwicklung und Charakterisierung einer Matrix-Tablette für CTDD]( "Formulierungsentwicklung und Charakterisierung einer Matrix-Tablette für CTDD")
Formulierungsentwicklung und Charakterisierung einer Matrix-Tablette für CTDD59,90 €![Développement de la formulation et caractérisation d'une matrice de comprimés pour le CTDD]( "Développement de la formulation et caractérisation d'une matrice de comprimés pour le CTDD")
Développement de la formulation et caractérisation d'une matrice de comprimés pour le CTDD39,99 €![Razrabotka receptury i harakteristika matrichnoj tabletki dlq CTDD]( "Razrabotka receptury i harakteristika matrichnoj tabletki dlq CTDD")
Razrabotka receptury i harakteristika matrichnoj tabletki dlq CTDD16,99 €![Sviluppo della formulazione e caratterizzazione della compressa a matrice per CTDD]( "Sviluppo della formulazione e caratterizzazione della compressa a matrice per CTDD")
Sviluppo della formulazione e caratterizzazione della compressa a matrice per CTDD39,99 €![Sustain Release Matrix Tablet of Cinnarizine]( "Sustain Release Matrix Tablet of Cinnarizine")
Sustain Release Matrix Tablet of Cinnarizine32,99 €![Formulation & Evaluation of Dexamethasone Matrix]( "Formulation & Evaluation of Dexamethasone Matrix")
Formulation & Evaluation of Dexamethasone Matrix39,99 €
The present investigation involves formulation development and characterization pg matrix tablet for colon targeted delivery with a view to extended the drug release in colonic segment. The extended release matrix tablet were formulated by using the combination of release retardant polymer. The polymer used were hydroxypropylmethylcellulose, eudragit L-30.D55. tablet were prepared by wet granulation technique using water. The granules were subjected to pre-compression evaluation such as bulk density, tap density, compressibility index, hausners ratio, particle size distribution and loss on drying. It was concluded that granules exhibited good compressibility and flow property. Prepared tablet were also evaluated for post-compression parameter like hardness, thickness, in-vitro dissolution, stability studies. Amongs the eight formulations F8 showed good results In-vitro dissolution studies were carried out for 12 hrs using 0.1 N HCl for 2 hrs and pH 7.2 for remaining 10 hrs. In-vitro dissolution studies showed that the formulation F8 releases 91.9 % of drug. Stability studies were carried out for formulayion F8 at 25 C/60% RH and 40 C/75% RH for 30 days.